Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zeo ScientifiXZEOX 47 3-1 Month Momentum % is 4.00% as of Aug. 20, 2026. GuruFocus rates ZEOX with a GF Score™ of 47/100 and a GF Value™ of $2.63 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,386 Biotechnology companies, Zeo ScientifiX ranks better than 67.24% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-20), Zeo ScientifiX's 3-1 Month Momentum % is 4.00%.
The industry rank for Zeo ScientifiX's 3-1 Month Momentum % or its related term are showing as below:
ZEOX's 3-1 Month Momentum % is ranked better than 67.24% of 1386
companies
in the Biotechnology industry
Industry Median: -5.39
vs ZEOX: 4.00
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Zeo ScientifiX 3-1 Month Momentum % Related Terms
ZEOX vs SNTI, BCDA, COCP: 3-1 Month Momentum % Comparison
For the Biotechnology subindustry, Zeo ScientifiX's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zeo ScientifiX 3-1 Month Momentum % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zeo ScientifiX's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Zeo ScientifiX's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zeo ScientifiX (ZEOX) has a 3-1 Month Momentum % of 4.00% as of Aug. 20, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Zeo ScientifiX and its competitors. According to the industry distribution chart, Zeo ScientifiX ranks #454 out of 1386 companies in the Biotechnology industry, placing it in the top 32.8%.
Is Zeo ScientifiX's 3-1 Month Momentum % too high?
Zeo ScientifiX's current 3-1 Month Momentum % is 4.00%. Based on the distribution chart, Zeo ScientifiX ranks #454 out of 1386 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Zeo ScientifiX has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zeo ScientifiX's 3-1 Month Momentum % compare to SNTI and BCDA?
According to the Biotechnology industry distribution chart, Zeo ScientifiX ranks #454 out of 1386 companies for 3-1 Month Momentum %. This puts Zeo ScientifiX in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Biotechnology company?
A good 3-1 Month Momentum % depends on the Biotechnology industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Zeo ScientifiX and its competitors. Zeo ScientifiX's current 3-1 Month Momentum % is 4.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zeo ScientifiX stock overvalued right now?
Based on GuruFocus' analysis, Zeo ScientifiX (ZEOX) is currently considered Possible Value Trap. The stock's GF Value™ is $2.63, compared to a current price of $1.33 — trading 49.3% below its estimated fair value. The current 3-1 Month Momentum % is 4.00%. Zeo ScientifiX's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Zeo ScientifiX (ZEOX), the current 3-1 Month Momentum % is 4.00% as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zeo ScientifiX (ZEOX) Overvalued in 2026?
Based on GuruFocus' analysis, Zeo ScientifiX stock appears to be undervalued.
The current stock price of $1.33 is trading 49.3% below its estimated GF Value™ of $2.63.
GuruFocus considers Zeo ScientifiX to be Possible Value Trap.
Key valuation signals for ZEOX:
3-1 Month Momentum %: 4.00%
GF Value™: $2.63 vs. price of $1.33 (49.3% below fair value)
No single metric tells the full story. See the ZEOX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. The Company is a clinical-stage biopharmaceutical company principally focusing on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company's proprietary products, including Zofin, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X (PPX ), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood (RAAM Products).
47GF Score
Get the complete analysis for ZEOX
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZEOX has been successfully added to your 
